Evidence map›Paper›PMID 25911241›Full record

ArticleInternational journal of surgery case reports2015

A unique presentation of a renal clear cell carcinoma with atypical metastases.

F Staderini, F Cianchi, B Badii, I Skalamera, G Fiorenza, C Foppa, E Qirici, G Perigli

Open access · goldAbstract read
In one paragraph

Article in International journal of surgery case reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Gallbladder's clear cell renal carcinoma metastasis: A case report.International journal of surgery case reports · 2016
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

F StaderiniUnit of General and Endocrine Surgery, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy. Electronic address: staderini.fabio@gmail.com.
F CianchiUnit of General and Endocrine Surgery, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy.
B BadiiUnit of General and Endocrine Surgery, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy.
I SkalameraUnit of General and Endocrine Surgery, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy.
G FiorenzaUnit of General and Endocrine Surgery, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy.
C FoppaUnit of General and Endocrine Surgery, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy.
E QiriciUnit of General and Endocrine Surgery, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy.
G PerigliUnit of General and Endocrine Surgery, Department of Surgery and Translational Medicine, University of Florence, Florence, Italy.
University of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionRenal cancer is a relatively common neoplasia with renal clear cell carcinoma being the most frequent histological type. This tumor has a strong tendency to metastasize virtually to all organs. Today, new diagnostic tools allow physicians to distinguish between those patients with "incidental findings" and those with advanced metastatic disease. PRESENTATION OF CASE: A 70-year-old male with multiple indolent subcutaneous masses underwent colonoscopy after a positive fecal screening test for colorectal carcinoma. A rectal lesion was discovered but biopsy was negative. CT scan revealed advanced renal cancer involving the peritoneal cavity, retroperitoneum and lung. Biopsy of subcutaneous masses confirmed the suspected metastases. The patient underwent surgery (an open left nephrectomy with rectosigmoid resection and metastases debulking) because of a high risk of bowel obstruction and increasing anemia. After three years of multi-targeted therapy and follow-up, the patient is still asymptomatic and in good general condition. DISCUSSION: Treatment of metastatic renal cancer is still controversial even if more than 30% of patients have metastasis at the time of diagnosis. Recently introduced targeted therapies are encouraging but still present problems with side effects and an unlimited period of efficacy. Although there is no consensus, several studies and guidelines consider metastasectomy to be a valid option.

conclusionRecent series highlight surgery as a key-point in the management of advanced renal clear cell carcinoma. Our case demonstrates the validity of a surgical strategy supported by a multidisciplinary approach.

Indexed as

Kidney cancerMetastasectomyMetastasesNephrectomyRenal clear cell carcinomaTargeted therapies

Identifiers

PMID25911241
PMCPMC4446666
OpenAlexW2171855861

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.